Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Zimmer Biomet Holdings Inc (NYSE: ZBH) closed at $92.27 down -0.52% from its previous closing price of $92.75. In other words, the price has decreased by -$0.52 from its previous closing price. On the day, 1.67 million shares were traded. ZBH stock price reached its highest trading level at $93.72 during the session, while it also had its lowest trading level at $92.34.
Ratios:
For a deeper understanding of Zimmer Biomet Holdings Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.15 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.15. For the most recent quarter (mrq), Quick Ratio is recorded 1.39 and its Current Ratio is at 2.43. In the meantime, Its Debt-to-Equity ratio is 0.64 whereas as Long-Term Debt/Eq ratio is at 0.59.
On September 18, 2025, Rothschild & Co Redburn started tracking the stock assigning a Buy rating and target price of $130.
Roth Capital Upgraded its Neutral to Buy on July 15, 2025, while the target price for the stock was maintained at $135.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 11 ’25 when Yi Sang sold 1,200 shares for $103.58 per share. The transaction valued at 124,302 led to the insider holds 18,584 shares of the business.
Yi Sang bought 1,200 shares of ZBH for $124,302 on Sep 11 ’25. On Sep 08 ’25, another insider, Winkler Lori, who serves as the SVP and CHRO of the company, sold 1,500 shares for $104.15 each. As a result, the insider received 156,225 and left with 6,833 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZBH now has a Market Capitalization of 18286211072 and an Enterprise Value of 25624956928. As of this moment, Zimmer’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.83, and their Forward P/E ratio for the next fiscal year is 10.84. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.43. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.28 while its Price-to-Book (P/B) ratio in mrq is 1.43. Its current Enterprise Value per Revenue stands at 3.199 whereas that against EBITDA is 9.705.
Stock Price History:
The Beta on a monthly basis for ZBH is 0.62, which has changed by -0.13244784 over the last 52 weeks, in comparison to a change of 0.12529528 over the same period for the S&P500. Over the past 52 weeks, ZBH has reached a high of $114.44, while it has fallen to a 52-week low of $85.33. The 50-Day Moving Average of the stock is -3.96%, while the 200-Day Moving Average is calculated to be -6.61%.
Shares Statistics:
For the past three months, ZBH has traded an average of 1.81M shares per day and 2093810 over the past ten days. A total of 198.20M shares are outstanding, with a floating share count of 197.90M. Insiders hold about 0.14% of the company’s shares, while institutions hold 99.76% stake in the company. Shares short for ZBH as of 1763078400 were 7547747 with a Short Ratio of 4.16, compared to 1760486400 on 7137828. Therefore, it implies a Short% of Shares Outstanding of 7547747 and a Short% of Float of 4.37.
Dividends & Splits
According to the company, the forward annual dividend rate for ZBH is 0.96, from 0.96 in the trailing year. Against a Trailing Annual Dividend Yield of 0.010350404. The stock’s 5-year Average Dividend Yield is 0.8. The current Payout Ratio is 21.66% for ZBH, which recently paid a dividend on 2025-09-30 with an ex-dividend date of 2025-09-30. Stock splits for the company last occurred on 2022-03-01 when the company split stock in a 103:100 ratio.
Earnings Estimates
Its stock is currently analyzed by 24.0 different market analysts. The consensus estimate for the next quarter is $1.92, with high estimates of $2.09 and low estimates of $1.78.
Analysts are recommending an EPS of between $8.23 and $8.11 for the fiscal current year, implying an average EPS of $8.17. EPS for the following year is $8.52, with 26.0 analysts recommending between $8.98 and $8.38.
Revenue Estimates
A total of 22 analysts believe the company’s revenue will be $2.22B this quarter.It ranges from a high estimate of $2.24B to a low estimate of $2.21B. As of. The current estimate, Zimmer Biomet Holdings Inc’s year-ago sales were $2.02BFor the next quarter, 22 analysts are estimating revenue of $2.07B. There is a high estimate of $2.12B for the next quarter, whereas the lowest estimate is $1.99B.
A total of 25 analysts have provided revenue estimates for ZBH’s current fiscal year. The highest revenue estimate was $8.23B, while the lowest revenue estimate was $8.16B, resulting in an average revenue estimate of $8.21B. In the same quarter a year ago, actual revenue was $7.68BBased on 24 analysts’ estimates, the company’s revenue will be $8.63B in the next fiscal year. The high estimate is $8.75B and the low estimate is $8.34B.
